miRNA arrays

NIH researchers have uncovered a blood-based microRNA signature that may be able to tell which patients with precursor disease may progress to myeloma.

The proof-of-principle application suggests networks of microRNA, RNA, and other 'omics data can untangle drug response and more.

NEW YORK (GenomeWeb) — Researchers interested in microRNA expression profiling today face a bevy of options including microarrays, quantitative PCR assays, and next-generation sequencing applications, but it is not always obvious which platform is the most suitable for a given study.

Exiqon continues to see demand for its microRNA microarray products, though its quantitative PCR assays and functional analysis products are driving its sales, according to its CEO Lars Kongsbak.

NEW YORK (GenomeWeb News) – A Medicare contractor has issued a final coverage determination confirming coverage for one of Rosetta Genomics' microRNA-based cancer diagnostics, but denying Medicare coverage for two of the firm's other tests, Rosetta announced today.

Rosetta Genomics has published a study describing the development and initial validation of its miRview Kidney test, a 24-microRNA array-based assay that classifies a patient's primary kidney tumor into one of four main subtypes.

With a handful of recently awarded grants, startup Circulomics is kicking off development of its technology as a tool for lower cost and more accessible multiplex analysis of disease-associated microRNAs, and is planning to launch its first kit, a 30-plex, semi-customizable cance

Affymetrix's latest offering to researchers studying microRNA continues to stand alone in the marketplace.

Three microRNAs have been implicated in the transformation of normal fibroblasts into cancer-promoting cells and could be potential drug targets in ovarian cancer, a study by University of Chicago and Northwestern University researchers has suggested.

NEW YORK (GenomeWeb News) – Takara Bio will distribute Exiqon's miRCURY LNA products in Asia beginning in January 2013, Exiqon announced today.

Pages

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.